BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.487
-0.043 (-1.70%)
At close: Sep 18, 2026, 4:00 PM EDT
2.540
+0.053 (2.13%)
After-hours: Sep 18, 2026, 7:30 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $11.24 million as of September 18, 2026. Its market cap has decreased by -29.98% in one year.
Market Cap
11.24M
Enterprise Value
8.99M
1-Year Change
-29.98%
Ranking
Category
Stock Price
$2.49
ChartMarket Cap Chart
Since July 25, 2011, BioLineRx's market cap has decreased from $68.58M to $11.24M, a decrease of -83.61%. That is a compound annual growth rate of -11.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 11.24M | -14.20% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 12.14M |
| Daré Bioscience | 11.85M |
| Theriva Biologics | 10.81M |
| Purple Biotech | 10.65M |
| Vistagen Therapeutics | 10.64M |
| Immuron | 10.56M |
| KALA BIO | 10.50M |
| Azitra | 10.49M |